https://www.targetedonc.com/view/esr1-mutations-may-signal-better-results-with-oral-serds-in-advanced-breast-cancer
0
0
10/9/23 at 5:00pm
Organization
Targetedonc.com
Author
Targeted Oncology Staff
42 words
0
Comments
At a live virtual event, Jane Lowe Meisel, MD, provided insights into the latest practice updates for patients with hormone receptor–positive, HER2-negative metastatic breast cancer.
You are the first to view
Create an account
or login to join the discussion